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Background: The purpose of this study is to report a previously undescribed clinical entity resembling acute
posterior multifocal placoid pigment epitheliopathy (APMPPE) but with an atypical, panretinal and diffuse
presentation in young patients with an HLA-A3 and HLA-C7 association. We describe a cluster of three, young,
healthy patients who experienced acute visual loss, aged 16 through 27 years exhibiting an unusual clinical entity
over an 8-month period.
Findings: Our patients demonstrated a unique presentation with acute retinal lesions similar to APMPPE but had
widespread presentation of multiple lesions in the peripheral retina. All three of our patients exhibited an acute loss
of vision, two of them bilaterally. Ophthalmoscopy and fundus photography demonstrated a diffuse distribution of
lesions located extensively throughout the retina. On fluorescein angiography, the lesions showed a characteristic
‘blocking early and staining late’ pattern similar to APMPPE. The average duration of activity was 6 weeks (range 4
to 8 weeks), and there were no recurrences and good visual prognosis. HLA-A3 and HLA-C7 was noted in 100% of
the patients. Ocular coherence tomography during the acute stage in one patient demonstrated thickening at the
RPE layer.
Conclusions: To our knowledge, this cluster of young patients represents a previously undescribed clinical entity,
with clinical features similar to APMPPE, relentless placoid chorioretinitis and ampiginous. Due to the diffuse
distributions of the active lesions, the acute clinical course without recurrences, good visual prognosis, and HLA-A3/
C7 association, we believe it to be distinct from these other white dot syndromes. All three patients experienced
preceding viral-like prodrome which, when combined with major histocompatibility commonalities, may predispose
these individuals to an immune response. We call this entity panretinal acute multifocal placoid pigment
epitheliopathy or PAMPPE.
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Background
Acute posterior multifocal placoid pigment epitheliopathy
(APMPPE) was first described by Gass, is used to de-
scribe an inflammatory disease that affects the fundus of
healthy young adults, both males and females, and is
associated with an acute onset temporary visual loss
[1-3]. APMPPE is characterized by the development of* Correspondence: Kevinrbaxter@gmail.com
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reproduction in any medium, provided the origmultiple gray-white, flat plaque-like lesions that are
located in the posterior pole at the level of the retinal
pigment epithelium (RPE) or choriocapillaris [1]. The
plaques vary in size, but are clearly defined. Clinically,
the disease presents with sudden onset of visual blurring
and/or flashing lights in patients younger than 30 years
of age [3]. It may be preceded with prodromal viral ill-
ness, along with headache and erythema nodosum [2,4].
Most cases are bilateral, but unilateral presentations with
delayed appearance of disease in the second eye within
several weeks have been noted. Typically, APMPPE is a
nonrecurring disorder, with relatively good visual prog-
nosis as 80% of patients regain 20/40 or better visualr. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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ously been reported with HLA-B7 and HLA-DR2 [5,6].
Other clinical entities that have been described in the
literature are relentless placoid chorioretinitis (RPC) and
ampiginous chorioretinopathy. These diseases have char-
acteristics similar to APMPPE and serpiginous choroidi-
tis but with atypical and chronic or recurrent clinical
course [7]. The lesions can be unilateral or bilateral, with
abrupt vision loss in the affected eye and delayed onset
possibly occurring in the other eye. RPC has been
reported to affect healthy men and women between the
ages 16 and 51 years [7,8]. Previous publications report
that there is typically greater than 50 lesions throughout
the retina with RPC. Jones and co-investigators have
reported that the retinal lesions seen with RPC resemble
APMPPE and serpiginous choroiditis, but the lesions
occurred in distinctive retinal distribution with pro-
longed relapsing clinical course. New active lesions have
been noted in patients as long as 24 months after initial
evaluation [7]. Overall prognosis of visual acuity shows a
positive trend. Ampiginous chorioretinopathy causes
progressive destruction of retina while sharing features
of both APMPPE and serpiginous choroiditis [9]. Its
chronic nature causes poor visual prognosis, and recur-
rences are common [4,9-14].
We describe three young Caucasian patients over an
8-month period, who presented with a distinct posterior
uveitis similar to relentless placoid chorioretinitis but
experienced an acute, non-recurrent clinical course simi-
lar to APMPPE. Four of five eyes involved had a final
visual acuity of 20/40 or better, and 100% of the patients
assayed had HLA-A3 and HLA-C7 association. Due to
the unique clinical presentation, acute clinical course
without recurrences, HLA association, and good visual
prognosis, we believe they represent a new clinical en-
tity called panretinal acute multifocal placoid pigment
epitheliopathy or PAMPPE.
Methods
We describe a cluster of young patients seen between
April and December of 2006. All lived in central Ohio
and were between the ages 16 and 27 (Table 1). The
three patients were examined and followed with Snellen
visual acuities, biomicroscopy, fundus examination, and
photography for a period of at least 4 years. Fluorescein
angiography and optical coherence tomography (OCT)
were performed as needed. All patients were evaluated
for known causes of posterior uveitis with uveitis review
of systems, physical examination, and laboratory testing.
The following laboratory testing evaluated in all three indi-
viduals included complete blood count, basic metabolic
panel, liver function panel, erythrocyte sedimentation rate,
C-reactive protein, blood cultures, HIV testing, Lyme titers,
angiotensin converting enzyme, rapid plasma reagent,fluorescent treponemal antibody absorption test, tuberculin
skin test (purified protein derivative), herpes simplex types I
and II serology, anti-nuclear antibody, toxoplasma titers,
and chest X-ray. One patient underwent brain MRI.
Human leukocyte antigen (HLA) testing was performed in
all three consenting patients. This is a retrospective review
of their clinical cases. All patient information and clinical
photographs were permitted by the patient with written
and signed consent from each patient.
Case 1
A 27-year-old Caucasian woman presented with sudden
decrease of vision in the left eye 3 weeks prior. Her
medical history was remarkable for ulcerative colitis and
non-specific upper respiratory tract infection approxi-
mately 6 weeks prior. A uveitis review of systems and
laboratory evaluation were unremarkable. Initial visual
acuities were 20/20 OD and 20/60 OS falling to 20/200
OD and 20/60 OS over several weeks. Intraocular pres-
sures were 15 mmHg OD and 14 mmHg OS. Anterior
segment findings were within normal limits OU, and no
cell or flare was present.
Initial dilated fundus examination revealed multifocal,
grayish/white lesions scattered throughout the fundus of
both eyes (Figure 1). The left eye had a large lesion from
arcade to arcade in the posterior pole along with lesions
in the peripheral retina. Fundus photography and fluor-
escein angiography demonstrated ‘block early stain late’
appearance (Figure 1). The right eye developed new
lesions over a 2-week period.
The patient was seen at 2, 4, 6, and 12 weeks, 6 months,
and one year for re-evaluation. After 1 year, the patient was
seen yearly for routine evaluation for 4 years total. The
patient did not receive any therapy or treatments. Visual
acuity improved to 20/20 OU by week 12 follow-up visit
and remained 20/20 at her 12-month follow-up and
subsequent evaluations. Fundus examination revealed wide-
spread and scattered areas of depigmentation, and both fine
and course clumping of the pigment epithelium located
throughout the posterior pole and the periphery in both
eyes without active disease were noted by 4 weeks. HLA
testing was performed, and class I antigens HLA-A3 and
HLA-C7 were identified (Table 1).
Case 2
This is a 17-year-old Caucasian male with a 1.5-week
history of decreased visual acuity, photophobia, and mild
ocular pain in his right eye. He had previously been in
the emergency room for a viral condition with GI pain,
vomiting, and fever approximately 2 months prior to the
onset of visual symptoms. Uveitis survey and past med-
ical history were remarkable for mild headaches and
psoriasis. Laboratory evaluation was unremarkable in-
cluding normal MRI, except for an elevated CRP at 12.3.
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OS. Intraocular pressures were 8 mmHg OD and 5 mmHg
OS. Anterior segment examination found 1+ cells in the
anterior chamber and 2+ cells in the vitreous cavity of the
right eye; left eye, within normal limits. Dilated fundus
examination found multiple, diffuse, creamy-white lesions
in both the posterior pole and peripheral retina (Figure 2).
Fundus photography and fluorescein angiography demon-
strated a ‘blocking early, staining late’ pattern. Due to the
intraocular inflammation, he was treated with oral
prednisone.
The patient was followed-up at 2, 4, 6, 8, and 12 weeks, 6
months, and 1 year for re-evaluation. The patient was then
followed yearly for a total of 4 years. The lesions evolved
over an 8-week period, with increasing size and number of
the retinal lesions, and he received a Subtenon's injection of
triamcinolone 40 mg. Two weeks after the initial evalu-
ation, the patient stated visual acuity had improved, with
best-corrected visual acuity at follow-up to be 20/200 OD.
The anterior segment had less inflammatory cell, and the
patient was continued on oral prednisone for a 6-week
period with slow taper. Following re-examination after 8
weeks, visual acuity and examination revealed further
improvement. Fundus examination noted diffuse retinal
pigment epithelial scarring throughout the retina (Figure 2).
The patient has not experienced any recurrences.
OCT examination during the acute phase showed
thickening at the RPE, along with normal foveal depres-
sion. HLA testing identified class I antigens HLA-A3
and HLA-C7.Case 3
This is a 16-year-old Caucasian male with a 2-week
history of decreasing visual acuity. Past medical history
was unremarkable, although he did report non-specific






Medical history Duration of
activity (weeks)




2/M/C/17 R 20/400 HA, GI, fever, MRI 8
3/M/C/16 R 20/400 Non-specific URI 4
L 20/50
C, Caucasian; HA, headache; GI, gastrointestinal symptoms; MRI, magnetic resonanc
CA, USA).and laboratory evaluation were unremarkable. At time of
ocular examination, visual acuity was 20/400 OD and
20/50 OS. Intraocular pressure was 15 mmHg OU.
Dilated fundus examination of the right eye found multi-
focal placoid hypopigmented lesions at the RPE. Examin-
ation of the left fundus showed a smaller number of
lesions (Figure 3). Fundus photography and fluorescein
angiography demonstrated multifocal and diffuse lesions
scattered throughout the posterior pole and peripheral
retina of both eyes.
Treatment plan was 30 mg prednisone taper, and con-
tinuation of oral ciprofloxacin BID started previously by
PCP for upper respiratory tract infection. Follow-up
examinations took place at the interval of 2, 4, 6, 8, and
12 weeks, and 6 months, and 1-year duration. The pa-
tient was then followed yearly for a total of 4 years. The
lesions resolved over a 4-week period with improved vis-
ual acuities to 20/60 OD and 20/20 OS by 12 weeks and
20/40 OD and 20/20 OS by 6 months (Figure 3). There
have been no recurrences. HLA testing was performed,
and HLA-A3 and HLA-C7 were present.Results
Our patients demonstrated a unique clinical presentation
with acute retinal lesions similar to APMPPE but with
more widespread presentation of multiple lesions in the
peripheral retina. All patients were young, Caucasian, and
exhibited an acute loss of vision, two of them bilaterally. All
three patients reported prior illness. Ophthalmoscopy and
fundus photography demonstrated a diffuse distribution of
lesions located throughout the retina. On fluorescein angi-
ography, the lesions showed a characteristic blocking-early-
and-staining-late pattern similar to APMPPE. The average
duration of activity was 6 weeks (range 4 to 8 weeks), and
there were no recurrences. Four of five affected eyes had






None 20/20 A 2/3
20/20 B 7/44
C 5/7
Prednisone, Subtenon's triamcinolone (Bristol-




Prednisone, PF 1%, oral ciprofloxacin 20/40 A 2/3
20/20 B 7/57
C 6/7
e imaging; URI, upper respiratory tract infection; PF, Pred Forte (Allergan, Inc.,
Baxter and Opremcak Journal of Ophthalmic Inflammation and Infection 2013, 3:29 Page 4 of 7
http://www.joii-journal.com/content/3/1/29and HLA-C7-positive. OCT during the acute stage in one
patient found thickening in the RPE.
Discussion
We present three patients whom we believe have a pre-
viously undescribed clinical entity called panretinal acute
multifocal placoid pigment epitheliopathy or PAMPPE.
The patients presented over an 8-month period in cen-
tral Ohio. All were young, Caucasian, and previously
healthy except one patient with inflammatory bowel dis-
ease. All patients had preceding viral-like prodrome.
There were more males (2:1), the disease was bilateral in
two of the three patients, and the clinical course was
acute lasting 4 to 8 weeks. All three patients presentedFigure 1 Case 1. A 27-year-old Caucasian female with a reduced initial VA
fundus upon initial examination with active lesions present in the peripher
presentation and diffuseness of the lesions located in the posterior pole OD
evaluation showing areas of active lesions along with hyperpigmented are
angiogram montage demonstrating the atypical presentation of the lesion
angiogram of left eye at 20 s showing early phase/hypofluorescence or blo
hyperfluorescence or staining of the active lesions at 5 min and 56 s.with sudden loss of vision. Ocular examination revealed
multi-focal, creamy-white lesions at the level of the RPE
distributed both in the posterior pole and peripheral ret-
ina. Fluorescein angiography demonstrated block-early-
and-stain-late pattern. The disease was not progressive
or recurrent. All patients underwent HLA testing, and
100% of the tested subjects were positive with HLA-A3
and HLA-C7. Two subjects (66%) were positive with
HLA-A2 and HLA-B7. The visual prognosis was good
with improvement in all subjects with 20/40 or better
vision in four of the five involved eyes.
APMPPE generally affects young individuals between
the age of 20 to 50 years, without gender predisposition
[5]. The etiology of APMPPE is still unknown. Gassof 20/200 OD and 20/60 OS due to PAMPPE. (A) Appearance of right
y. (B) Fluorescein angiogram montage demonstrating the atypical
. (C) Fundus photograph montage of left eye taken upon initial
as of scarring in the RPE of the posterior pole. (D) Fluorescein
s located in the posterior pole of the left eye. (E) Fluorescein
ckage upon initial evaluation along with (F) late phase/
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the development and resolution suggest that it repre-
sents an acute pigment epithelial response to local infec-
tious agents [15]. The lesions in APMPPE are classically
confined to the posterior pole and have been associated
with HLA-B7 [5]. Our patients demonstrated retinal
lesions similar to those in APMPPE but had more wide-
spread and panretinal distribution. Patients with RPC
have more lesions than those with APMPPE and areFigure 2 Case 2. A 17-year-old Caucasian male with visual acuity reduced
photography at initial evaluation with an atypical, panretinal, and diffuse p
characteristic early phase/hypofluorescence or blockage upon initial evalua
active lesions at 4 min and 58 s. (D) OCT examination during the acute ph
time of initial examination demonstrating the atypical, panretinal, and diffu
showed the presence of diffuse scarring in the RPE.persistent with prolonged periods of activity along with
relapses being common, resembling the clinical course
similar to serpiginous choroiditis [7]. The clinical
course of patients with RPC ranges from 5 to 24
months. Ampiginous chorioretinopathy is a cross be-
tween APMPPE and serpiginous choroiditis, and pre-
sents with RPE hyperpigmentation and atrophy in
inactive healing lesions [9]. Previous reports have also
associated serpiginous with HLA-B7 [5]. Similar to RPC,to 20/400 OD at initial examination due to PAMPPE. (A) Fundus
resentation. (B) Fluorescein angiogram of right eye at 30 s showing the
tion along with (C) late phase/hyperfluorescence or staining of the
ase with thickening of the RPE. (E) Fundus photograph montage at the
se active lesions. (F) Follow-up examination after 8-week duration
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Visual prognosis is poor in ampiginous choroidopathy.
In our three young, Caucasian patients, the mean dur-
ation of active lesions was 6 weeks, not recurrent, and
the visual prognosis was good.
We found that HLA-A3 and HLA-C7 were common
in all three (100%) of the patients. The estimated gene
frequency in the Caucasian population for HLA-A3 and
HLA-C7 has been reported to be 13% and 16%, respect-
ively. APMPPE and serpiginous have been reported to
have 40% association with HLA-B7. HLA-B7 has a gene
frequency of 12% in the Caucasian population. Two of
the three patients with PAMPPE (66%) had HLA-B7 and
HLA-A2.
These major histocompatibility (MHC) associations
and similarities found in our patients suggest a com-
mon susceptibility and pathophysiologic mechanism
for PAMPPE. A postulated theory for HLA-disease
association would suggest these common MHC anti-
gens (HLA-A3, A2, B7, and C7) predispose these
individuals when combined with prodromal virus orFigure 3 Case 3. A 16-year-old Caucasian male with visual acuity reduced
photograph of the right eye demonstrating a diffuse distribution of active
scarring of the RPE in the area of the macula. (B) Montage fundus photogr
scattered. Panels (C) and (D) show the fundus photography OU after 5 mo
diffuse scarring.viral particles. The resulting cell surface complex
would then be recognized as foreign by the host's im-
mune complex. This could then result in an auto-
immune response, directed at tissues bearing these
modified antigenic moieties. One of our patients had
an OCT during the acute phase showing a thickening
of the RPE, suggesting an immune response.
The most appropriate method of treatment for PAMPPE
is still to be determined. One of our patients received no
treatment. Two out of the three patients were treated
with oral prednisone, and one patient received
Famvir (Novartis AG, Basel, Switzerland) and Pred
Forte. The overall prognosis showed a positive trend
in all patients. Only one patient experienced minimal
improvement. Four of the five affected eyes had
visual improvement of 20/40 or better. Three of the
five eyes examined had a final visual acuity of 20/20.
We present a retrospective series of patients experien-
cing an atypical clinical entity resembling relentless placoid
chorioretinitis but with a shorter duration of activity
similar to APMPPE, no recurrences, good visual prognosis,to 20/400 OD and 20/50 OS at initial examination. (A) Montage fundus
lesions located extensively throughout the entire retina, along with
aph of the left eye showed creamy white active lesions diffusely
nths, showing no recurrences of active lesions and the presence of
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adults. All three patients experienced preceding viral ill-
ness, with no other environmental commonalities. To our
knowledge, no previous literature has expressed any similar
discoveries. We believe this to be a new clinical entity,
which we are calling panretinal acute multifocal placoid
pigment epitheliopathy or PAMPPE.
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